Fundraising Fox

Katie Ellias

Investor

Managing Partner at JDRF T1D Fund

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Katie Ellias is a Venture Partner at Zubi Capital with over a decade of venture capital experience in life sciences, including biotech, medical devices, and digital health. She previously served as Managing Director of a single disease impact fund focused on venture philanthropy from 2018 to 2024, and has held board director and observer positions at 12+ early and later-stage companies across the US, Canada, and Europe. Her background includes product launches in interventional cardiology and expertise in cardiac surgery, structural heart, diabetes, and global M&A transactions.

Experience

  1. Zubi CapitalVenture Partnercurrent2025 — present
  2. KE Advisory LLCAdvisor/Consultantcurrent2025 — presentCambridge, MA
  3. SAb BiotherapeuticsBoard Membercurrent2023 — present
  4. FACCNE ⎮ French-American Chamber of Commerce, New EnglandBoard Membercurrent2025 — presentBoston, Massachusetts, United States
  5. WHARTON HEALTH CARE MANAGEMENT ALUMNI ASSOCIATIONVice President and Board Membercurrent2021 — presentPhiladelphia, Pennsylvania, United States
  6. T1D FundManaging Director2018 — 2024Boston, Massachusetts, United States
  7. SeraxisBoard Observer2021 — 2024Germantown, Maryland, United States
  8. DiogenXBoard Member2020 — 2024Marseille, Provence-Alpes-Côte d'Azur, France
  9. i2o TherapeuticsBoard Observer2020 — 2024Cambridge, Massachusetts, United States
  10. BiolinqBoard Observer2019 — 2024San Diego, California, United States
  11. VERALOX TherapeuticsBoard Member2019 — 2024Frederick, Maryland, United States
  12. Enthera PharmaceuticalsBoard Observer2018 — 2024Milan, Lombardy, Italy
  13. Capillary BiomedicalBoard Member2019 — 2022Irvine, California, United States
  14. Inversago PharmaBoard Observer2019 — 2021Montreal, Quebec, Canada
  15. Protomer TechnologiesBoard Observer2020 — 2021Pasadena, California, United States
  16. Pandion Therapeutics (acquired by Merck)Board Observer2019 — 2020Cambridge, Massachusetts, United States
  17. Tech HealthIndependent Consultant2017 — 2018Greater Paris Metropolitan Region
  18. Endeavour VisionSenior Investment Director2016 — 2017Geneva, Paris
  19. Sofinnova PartnersPrincipal2011 — 2016Greater Paris Metropolitan Region
  20. MedtronicProgram Director Medtronic EUreka2009 — 2011Lausanne, Vaud, Switzerland

Education

  1. The Wharton SchoolMBA, Health Care2004 — 2006
  2. Yale UniversityBA, Political Science1996 — 2000
  3. BB&N

Skills & more

StartupsVenture FinancingExecutive Coaching1Compensation Committee1Cross border1FinanceBoard DevelopmentDue DiligenceInternational Business DevelopmentDeal ExecutionInterpersonal SkillsBoard Level
+12 moreBusiness DevelopmentProduct LaunchMarketingNegotiationInterventional CardiologyCardiac SurgeryMedical DevicesCommercializationStrategyManagementLeadershipCross-functional Team Leadership

Languages English · French

From Katie's professional profile.

Colleagues at JDRF T1D Fund

Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Amy Montalto
Investor at JDRF T1D Fund
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Frank Martin
Investment Committee at JDRF T1D Fund

Network1

Amy Montalto
Investor at JDRF T1D Fund

Investors connected to Katie in public investor directories — a warm-intro map.

Frequently asked questions

Where does Katie Ellias work?
Katie Ellias is Managing Partner at JDRF T1D Fund.
What check size does Katie Ellias write?
Katie Ellias typically writes checks of $100K – $5M.

Same school

Also attended The Wharton School1,481

Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst

+ 1,475 more

Also attended Yale University619

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)

+ 613 more

Shared employers

Also worked at T1D Fund6

Ross CastilloInvestor at De Novo VenturesLucio IannoneVice President at Leaps by BayerRachel CottonInvestor at MPM BioImpactJonathan BehrPartner at SV Health InvestorsJohn BallewSenior Associate at JDRF T1D FundAmy MontaltoInvestor at JDRF T1D Fund

Also worked at Enthera Pharmaceuticals5

Christian SchubertHead of AbbVie Ventures at AbbVieAnta GkelouPartner, Capital Strategy at Sofinnova PartnersMargarita ChavezManaging Director at AbbVieDonmienne LeungDirector II, Head of AbbVie Ventures Europe at AbbVieJonathan BehrPartner at SV Health Investors

Also worked at Protomer Technologies1

Seth LieblichInvestment Team at 8VC

Also worked at Medtronic70

Paul SlosarInvestor at FortySix Venture CapitalJay W. SchmelterCo-founder of RiverVest Venture Partners, funding and founding life science companiesAshley ArchibequeExecutive Assistant at Two Bear CapitalDavid RodriguezInvestor at Draft Ventures LlcEvan PritchardSenior Managing Director & Co-Founder at JStar Capital InvestmentsAzin ParhizgarManaging Director, US at 415 Capital

+ 64 more